# Vaccine Therapy Plus QS21 in Treating Women With Breast Cancer Who Have No Evidence of Disease

> **NCT00003357** · PHASE1 · COMPLETED · sponsor: **Memorial Sloan Kettering Cancer Center** · enrollment: 9 (estimated)

## Conditions studied

- Breast Cancer

## Interventions

- **BIOLOGICAL:** GM2-KLH vaccine
- **BIOLOGICAL:** QS21

## Key facts

- **NCT ID:** NCT00003357
- **Lead sponsor:** Memorial Sloan Kettering Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1998-01
- **Primary completion:** 2001-11
- **Final completion:** 2001-11
- **Target enrollment:** 9 (ESTIMATED)
- **Last updated:** 2012-12-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00003357

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00003357, "Vaccine Therapy Plus QS21 in Treating Women With Breast Cancer Who Have No Evidence of Disease". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00003357. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*